Could sarcopenia-related mortality in end-stage renal disease be underpinned by the number of hospitalizations and cardiovascular diseases?
Hugo de Luca CorrêaAndré Bonadias GadelhaBaruch VainshelboimMaurílio Tiradentes DutraJoão B Ferreira-JúniorLysleine Alves DeusRodrigo Vanerson Passos NevesAndrea Lucena ReisThaís Branquinho de AraújoCarmen Tzanno-MartinsFernanda Silveira TavaresRosângela Vieira AndradeThiago Dos Santos RosaPublished in: International urology and nephrology (2022)
Sarcopenia may be a risk factor for hospitalizations, cardiovascular diseases, and all-cause mortality in patients with ESRD. These results provide support of the relevance in assessing sarcopenia in the clinical practice of chronic kidney disease and how muscle mass and strength may negatively impact the daily life of ESRD patients undergoing hemodialysis. Greater efforts at preventing muscle wasting and malfunctioning are needed through the worldwide healthcare system.
Keyphrases
- end stage renal disease
- chronic kidney disease
- skeletal muscle
- peritoneal dialysis
- cardiovascular disease
- patients undergoing
- clinical practice
- community dwelling
- cardiovascular events
- type diabetes
- physical activity
- cardiovascular risk factors
- risk factors
- quality improvement
- metabolic syndrome
- coronary artery disease